Browsing: Immune disorders and inflammation
Natsume et al. summarize approaches with adoptive immunotherapies using genetically modified T cells, which have been improved by enhancing their antitumor activity, and discuss strategies to further develop these therapies.
Lauren Pulling highlights some of the key trending topics in neurology and neuroscience from 2016, as well as the top read articles of the year – take a look and let us know your thoughts.
A retrospective review of medical records reveals that the presence of a novel autoantibody in a patient’s serum is indicative of autoimmune meningoencephalomyelitis.
We speak to David Vigerust, author of ‘Neuroinflammation: a precursor and promoter of oncogenesis’, about his research and the role of trauma in oncogenesis.
In a computer-based study of response times, Crohn’s sufferers displayed an average cognitive function slower than that of healthy individuals.
This article aims to provide an up-to-date review of oxidative stress biomarkers in multiple sclerosis and thus identify candidate molecules with greatest promise as biomarkers of diagnosis, disease activity or prognosis.
Research into Caenorhabditis elegans has suggested manipulation of dopamine signaling could control gut inflammation. The results imply that drugs currently utilized in the nervous system, such as antipsychotics, might be repurposed to control the immune system.
New findings have indicated a potential link between mitoxantrone and an increased risk of colorectal cancer.
Long-term analysis details 10 years of clinical efficacy of alemtuzumab (Lemtrada®) in patients with relapsing-remitting multiple sclerosis.